Cervical Cancer Biden May Stop His Cancer Moonshot’s LaunchBy adminJune 15, 20220 In his last year as vice president, Joe Biden launched a “cancer moonshot” to accelerate cures for the disease. It…
Cervical Cancer ImCheck fetches €96M for antibodies that activate immune cells against cancerBy adminJune 14, 20220 Cancer immunotherapy’s scope is expanding with drugs that take new approaches to target more types of immune cells. ImCheck…
Endometrial Cancer PMV’s ASCO data show signs of drugging ‘undruggable’ p53 protein across tumor typesBy adminJune 8, 20220 The tumor-suppressing protein p53 has long been considered a valuable target—if only drug hunters could figure out how to…
Gynecologic Cancers Regeneron is paying $900M for full rights to cancer drug partnered with SanofiBy adminJune 2, 20220 Immuno-oncology drug Libtayo is Regeneron Pharmaceuticals’ main cancer asset, a product that is marketed under an alliance with Sanofi…
